IMU 0.00% 26.0¢ imugene limited

new vax licencing deal iminent

  1. 4,996 Posts.
    Upon successful completion of the trials and license negotiations and obtaining marketing authorisation Abic Biological Laboratories Teva Ltd will produce, sell and distribute the vectored coccidia vaccine with Imugene receiving royalty income. Abic is represented in the major poultry producing regions of the world.

    Coccidia treatment (coccidiostats) is the second biggest poultry treatment product category, second only to in-feed antibiotics. In 2004 in the UK, coccidiostats accounted for 31% of antimicrobial sales (by tonne) for all food animals. In the USA in 2001, 74% of all poultry producers used some form of coccidiostat accounting for an increased cost per tonne of food of ~$US3.00. An estimated market for coccidiostats in the US using these figures is ~$US100 million per annum.
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.243B
Open High Low Value Volume
26.0¢ 29.0¢ 24.8¢ $13.70M 50.80M

Buyers (Bids)

No. Vol. Price($)
2 733891 25.5¢

Sellers (Offers)

Price($) Vol. No.
26.0¢ 312347 9
View Market Depth
Last trade - 16.10pm 07/05/2021 (20 minute delay) ?
0.000 ( 1.09 %)
Open High Low Volume
26.0¢ 29.0¢ 24.5¢ 28967533
Last updated 15.59pm 07/05/2021 (live) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.